51 – 60 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma
(
- Contribution to journal › Article
-
Mark
The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness
(
- Contribution to journal › Article
- 2005
-
Mark
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
(
- Contribution to journal › Article
-
Mark
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
(
- Contribution to journal › Article
-
Mark
Intervention thresholds for osteoporosis in the UK
(
- Contribution to journal › Article
- 2004
-
Mark
Using burden of disease/cost-effectiveness as an instrument for district health planning: experiences from Uganda.
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
(
- Contribution to journal › Article
- 2003
-
Mark
The relative cost-efficiency of arable nitrogen management in Sweden
(
- Contribution to journal › Article
- 2002
-
Mark
Intervention thresholds for osteoporosis
(
- Contribution to journal › Article
- 2001
-
Mark
Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study
(
- Contribution to journal › Article